Last update 01 Nov 2024

Medical Parkland Co., Ltd.

Japan

Overview

Tags

Cardiovascular Diseases
Nervous System Diseases
Eye Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases2
Top 5 Drug TypeCount
Small molecule drug2
Top 5 TargetCount
ADRA2(Adrenergic receptors alpha-2)1
PDE x PDE4A x PDE5A1

Related

2
Drugs associated with Medical Parkland Co., Ltd.
Clonidine Hydrochloride
Target
ADRA2
Mechanism
ADRA2 agonists
Active Org.
Shandong Dayin Oceanic Biochemicals Co. Ltd.Shandong Dayin Oceanic Biochemicals Co. Ltd. [+10]
Originator Org.
Boehringer Ingelheim GmbHBoehringer Ingelheim GmbH
Active Indication
Attention Deficit Disorder With Hyperactivity [+8]
Inactive Indication
Chemotherapy oral mucositis [+5]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
JP
First Approval Date15 May 1969
Dipyridamole
Target
PDE x PDE4A x PDE5A
Mechanism
PDE inhibitors [+3]
Active Org.
Medical Parkland Co., Ltd. [+1]
Originator Org.
Boehringer Ingelheim GmbHBoehringer Ingelheim GmbH
Active Indication
Angina Pectoris [+2]
Inactive Indication
Postoperative Complications
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
JP
First Approval Date05 Feb 1960
100 Clinical Results associated with Medical Parkland Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Medical Parkland Co., Ltd.
Login to view more data
100 Deals associated with Medical Parkland Co., Ltd.
Login to view more data
100 Translational Medicine associated with Medical Parkland Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Dipyridamole
 ( PDE x PDE4A x PDE5A )		Heart Failure
More
Approved
Clonidine Hydrochloride
 ( ADRA2 )		Hypertension, Renal
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free